Screening strategies for tuberculosis prevalence surveys: the value of chest radiography and symptoms.
BACKGROUND
We conducted a tuberculosis (TB) prevalence survey and evaluated the screening methods used in our survey, to assess if screening in TB prevalence surveys could be simplified, and to assess the accuracy of screening algorithms that may be applicable for active case finding.


METHODS
All participants with a positive screen on either a symptom questionnaire, chest radiography (CXR) and/or sputum smear microscopy submitted sputum for culture. HIV status was obtained from prevalent cases. We estimated the accuracy of modified screening strategies with bacteriologically confirmed TB as the gold standard, and compared these with other survey reports. We also assessed whether sequential rather than parallel application of symptom, CXR and HIV screening would substantially reduce the number of participants requiring CXR and/or sputum culture.


RESULTS
Presence of any abnormality on CXR had 94% (95%CI 88-98) sensitivity (92% in HIV-infected and 100% in HIV-uninfected) and 73% (95%CI 68-77) specificity. Symptom screening combinations had significantly lower sensitivity than CXR except for 'any TB symptom' which had 90% (95%CI 84-95) sensitivity (96% in HIV-infected and 82% in HIV-uninfected) and 32% (95%CI 30-34) specificity. Smear microscopy did not yield additional suspects, thus the combined symptom/CXR screen applied in the survey had 100% (95%CI 97-100) sensitivity. Specificity was 65% (95%CI 61-68). Sequential application of first a symptom screen for 'any symptom', followed by CXR-evaluation and different suspect criteria depending on HIV status would result in the largest reduction of the need for CXR and sputum culture, approximately 36%, but would underestimate prevalence by 11%.


CONCLUSIONS
CXR screening alone had higher accuracy compared to symptom screening alone. Combined CXR and symptom screening had the highest sensitivity and remains important for suspect identification in TB prevalence surveys in settings where bacteriological sputum examination of all participants is not feasible.
Kenya Medical Research Institute/Center for Disease Control Research and Public Health Collaboration, Kisumu, Kenya. a.h.vanthoog@amc.uva.nl
Anna H
AH
van't Hoog
Helen K
HK
Meme
Kayla F
KF
Laserson
Janet A
JA
Agaya
Benson G
BG
Muchiri
Willie A
WA
Githui
Lazarus O
LO
Odeny
Barbara J
BJ
Marston
Martien W
MW
Borgdorff
D060085:Coinfection; D015658:HIV Infections / Q000175:diagnosis; D006801:Humans; D007630:Kenya; D008400:Mass Chest X-Ray; D008403:Mass Screening; D015995:Prevalence; D012680:Sensitivity and Specificity; D011795:Surveys and Questionnaires; D014376:Tuberculosis / Q000175:diagnosis* / Q000453:epidemiology* / Q000517:prevention & control